Phillip Fleshner
Expertise in
18
conditions

Dr. Phillip Fleshner

Colorectal Surgery
Cedars-Sinai Colorectal Surgery Center-Los Angeles
8737 Beverly Blvd Ste 101, 
West Hollywood, CA 
Expertise in
18
conditions
Cedars-Sinai Colorectal Surgery Center-Los Angeles
8737 Beverly Blvd Ste 101, 
West Hollywood, CA 

Overview

Phillip Fleshner is a Colorectal Surgeon in West Hollywood, California. Dr. Fleshner is highly rated in 18 conditions, according to our data. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Viral Gastroenteritis, Ileostomy, and Small Bowel Resection.

His clinical research consists of co-authoring 151 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Colorectal Surgery

Licenses

Colon & Rectal Surgery in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Cedars-Sinai Colorectal Surgery Center-Los Angeles
8737 Beverly Blvd Ste 101, West Hollywood, CA 90048

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Biological, Other
Study Drug: Darvadstrocel Adipose Stem Cell Transplantation
Study Phase: Phase 3
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection
Enrollment Status: Completed
Publish Date: June 23, 2023
Intervention Type: Drug
Study Phase: Phase 2
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic
Enrollment Status: Completed
Publish Date: December 27, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
Prospective Randomized Controlled Trial Investigating Commencement of Low Residue Diet Versus Clear Liquids on Postoperative Zero Following Elective Colorectal Surgery
Prospective Randomized Controlled Trial Investigating Commencement of Low Residue Diet Versus Clear Liquids on Postoperative Zero Following Elective Colorectal Surgery
Enrollment Status: Completed
Publish Date: January 31, 2020
Intervention Type: Device, Dietary supplement
Study Phase: Not Applicable
Prospective Randomized Control Study on Effect of Post Operative Loperamide in Decreasing Readmission for Dehydration in Colorectal Patients After Diverting Ileostomies
Prospective Randomized Control Study on Effect of Post Operative Loperamide in Decreasing Readmission for Dehydration in Colorectal Patients After Diverting Ileostomies
Enrollment Status: Terminated
Publish Date: December 20, 2017
Intervention Type: Drug
Study Phase: Phase 3
Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
Enrollment Status: Completed
Publish Date: September 13, 2017
View 6 Less Clinical Trials

151 Total Publications

Evaluation of TU-100 (Daikenchuto), a Traditional Japanese Kampo Medicine, As an Adjunct to Enhanced Recovery After Surgery, for Acceleration of Gastrointestinal Recovery After Bowel Resection - Results of a Proof-of-Concept, Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
Evaluation of TU-100 (Daikenchuto), a Traditional Japanese Kampo Medicine, As an Adjunct to Enhanced Recovery After Surgery, for Acceleration of Gastrointestinal Recovery After Bowel Resection - Results of a Proof-of-Concept, Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Diseases of the colon and rectum
Published: October 20, 2025
Similar Doctors
Expertise in
15
conditions
Dr. Karen Zaghiyan
Colorectal Surgery
Expertise in
15
conditions
Dr. Karen Zaghiyan
Colorectal Surgery

Cedars-Sinai Colorectal Surgery Center - Los Angeles

8737 Beverly Blvd Ste 101, 
West Hollywood, CA 
 (0.6 miles away)
310-289-9224
Languages Spoken:
English
See accepted insurances

Karen Zaghiyan is a Colorectal Surgeon in West Hollywood, California. Dr. Zaghiyan is highly rated in 15 conditions, according to our data. Her top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Anal Fissure, Ileostomy, and Hemorrhoidectomy.

Expertise in
20
conditions
Dr. Andreas Kaiser
Colorectal Surgery
Expertise in
20
conditions
Dr. Andreas Kaiser
Colorectal Surgery

Duarte Cancer Center

1500 Duarte Rd, 
Duarte, CA 
 (23.7 miles away)
866-486-1913
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andreas Kaiser is a Colorectal Surgeon in Duarte, California. Dr. Kaiser is highly rated in 20 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Bowel Incontinence, Colostomy, and Hernia Surgery.

Expertise in
10
conditions
Dr. Kevork Kazanjian
Colorectal Surgery
Expertise in
10
conditions
Dr. Kevork Kazanjian
Colorectal Surgery

UCLA Healt Colorectal Surgery

200 UCLA Medical Plz Ste 214, 
Los Angeles, CA 
 (3.5 miles away)
310-794-7788
Languages Spoken:
English
See accepted insurances

Kevork Kazanjian is a Colorectal Surgeon in Los Angeles, California. Dr. Kazanjian is highly rated in 10 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Bladder Reconstruction, and Hernia Surgery.

Frequently Asked Questions about Dr. Phillip Fleshner

How do I make an appointment with Dr. Phillip Fleshner?

You can book an appointment with Dr. Phillip Fleshner by calling their office at 310-289-9224. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Phillip Fleshner a top-rated expert for Crohn's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Phillip Fleshner is classified as an Elite expert for Crohn's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Phillip Fleshner specialize in?

While Dr. Phillip Fleshner is a Colorectal Surgery, they have specific expertise in Crohn's Disease, Ileostomy, and Ulcerative Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Colorectal Surgery.

Does Dr. Phillip Fleshner participate in research or clinical trials?

Yes. Dr. Phillip Fleshner has published 151 articles and abstracts on conditions like Crohn's Disease. You can view a list of Dr. Phillip Fleshner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Phillip Fleshner accept my insurance?

Dr. Phillip Fleshner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-289-9224 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fleshner's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile